AstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial Post author:Sam Post published:January 25, 2018 Post category:BioPharma Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace You Might Also Like FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab July 30, 2017 AEterna Zentaris Announces Presentation Regarding Macrilen At 99th Annual Meeting Of March 2, 2017 Zivo Bioscience, Inc. Kicks Off Final Phase Of Bovine Mastitis Study September 10, 2017
